Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing

Nature

Volumn 510, Issue 7506, 2014, Pages 537-541

  Hovestadt, Volker ^a   Jones, David T W ^a   Picelli, Simone ^a   Wang, Wei ^a   Kool, Marcel ^a   Northcott, Paul A ^a   Sultan, Marc ^b   Stachurski, Katharina ^c   Ryzhova, Marina ^d   Warnatz, Hans Jörg ^b   Ralser, Meryem ^b   Brun, Sonja ^e   Bunt, Jens ^f,g   Jäger, Natalie ^a   Kleinheinz, Kortine ^a   Erkek, Serap ^a,h   Weber, Ursula D ^a   Bartholomae, Cynthia C ^a   Von Kalle, Christof ^a   Lawerenz, Chris ^a   Eils, Jürgen ^a   Koster, Jan ^g   Versteeg, Rogier ^g   Milde, Till ^a,i   Witt, Olaf ^a,i   Schmidt, Sabine ^a   Wolf, Stephan ^a   Pietsch, Torsten ^j   Rutkowski, Stefan ^k   Scheurlen, Wolfram ^l   Taylor, Michael D ^m,n   Brors, Benedikt ^a   Felsberg, Jörg ^a,c   Reifenberger, Guido ^a,c   Borkhardt, Arndt ^c   Lehrach, Hans ^b   Wechsler Reya, Robert J ^e   Eils, Roland ^a,o   Yaspo, Marie Laure ^b   Landgraf, Pablo ^c   Korshunov, Andrey ^a,o   Zapatka, Marc ^a   Radlwimmer, Bernhard ^a   Pfister, Stefan M ^a,i   Lichter, Peter ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d BURDENKO NEUROSURGICAL INSTITUTE   (Russian Federation)

^e BURNHAM INSTITUTE   (United States)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

ⁱ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^j UNIVERSITY HOSPITAL BONN   (Germany)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l Cnopf'Sche Kinderklinik Nü Rnberg Children's Hospital   (Germany)

^m HOSPITAL FOR SICK CHILDREN   (Canada)

ⁿ UNIVERSITY OF TORONTO   (Canada)

^o UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA; LET 7 PROTEIN; LIN28B PROTEIN; MESSENGER RNA; MICRORNA; PROTEIN; TRANSCRIPTION FACTOR OTX2; TRANSCRIPTOME; UNCLASSIFIED DRUG;

CHILD HEALTH; DNA; GENE EXPRESSION; GENETIC ANALYSIS; GENOMICS; METHYLATION; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; EPIGENETICS; EXON; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; HETEROCHROMATIN; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; RNA SEQUENCE;

MURINAE;

ANIMALS; BINDING SITES; CELL LINE, TUMOR; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENOME; HISTONES; HUMANS; MEDULLOBLASTOMA; MICE; PROMOTER REGIONS, GENETIC; RNA-BINDING PROTEINS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84903516439     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13268     Document Type: Article

References (48)

1. Shen, H. & Laird, P. W. Interplay between the cancer genome and epigenome. Cell 153, 38-55 (2013).
2. Taylor, M. D. et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 123, 465-472 (2012).
3. Jones, D. T. W. et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 488, 100-105 (2012).
4. Northcott, P. A. et al. Medulloblastomics: the end of the beginning. Nature Rev. Cancer 12, 818-834 (2012).
5. Hovestadt, V. et al. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol. 125, 913-916 (2013).
6. Lister, R. et al. Global epigenomic reconfiguration during mammalian brain development. Science 341, 1237905 (2013).
7. Hong, C. et al. Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth. Proc. Natl Acad. Sci. USA 104, 10974-10979 (2007).
8. Gaur, T. et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 280, 33132-33140 (2005).
9. Doi, A. et al. Differential methylation of tissue-And cancer-specific CpG island shores distinguishes humaninduced pluripotent stemcells, embryonic stemcells and fibroblasts. Nature Genet. 41, 1350-1353 (2009).
10. Hansen, K. D. et al. Increased methylation variation in epigenetic domains across cancer types. Nature Genet. 43, 768-775 (2011).
11. Irizarry, R. A. et al. The human colon cancer methylome shows similar hypo-And hypermethylation at conserved tissue-specific CpG island shores. Nature Genet. 41, 178-186 (2009).
12. Hodges, E. et al. Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Mol. Cell 44, 17-28 (2011).
13. Yang, Z. J. et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 14, 135-145 (2008).
14. Cho, Y. J. et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J. Clin. Oncol. 29, 1424-1430 (2011).
15. Shyh-Chang, N.&Daley, G. Q. Lin28: primal regulator of growth andmetabolismin stem cells. Cell Stem Cell 12, 395-406 (2013).
16. Molenaar, J. J. et al. LIN28Binduces neuroblastomaandenhancesMYCNlevels via let-7 suppression. Nature Genet. 44, 1199-1206 (2012).
17. Berman, B. P. et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-Associated domains. Nature Genet. 44, 40-46 (2012).
18. Hon, G. C. et al. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res. 22, 246-258 (2012).
19. Lister, R. et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315-322 (2009).
20. Wen, B.,Wu, H., Shinkai, Y., Irizarry, R. A. & Feinberg, A. P. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nature Genet. 41, 246-250 (2009).
21. Schuster-Böckler, B. & Lehner, B. Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature 488, 504-507 (2012).
22. Aran, D., Toperoff, G., Rosenberg, M. & Hellman, A. Replication timing-related and gene body-specific methylation of active human genes. Hum. Mol. Genet. 20, 670-680 (2011).
23. Jeong, M. et al. Large conserved domains of low DNA methylation maintained by Dnmt3a. Nature Genet. 46, 17-23 (2014).
24. Xie, W. et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell 153, 1134-1148 (2013).
25. Tanay, A., O'Donnell, A. H., Damelin, M. & Bestor, T. H. Hyperconserved CpG domains underlie Polycomb-binding sites. Proc. Natl Acad. Sci. USA 104, 5521-5526 (2007).
26. Manoranjan, B. et al. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity ofmedulloblastomastemcells. Stem Cells 31, 1266-1277 (2013).
27. Ohm, J. E. et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes toDNA hypermethylation and heritable silencing. Nature Genet. 39, 237-242 (2007).
28. Schlesinger, Y. et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nature Genet. 39, 232-236 (2007).
29. Bunt, J. et al. OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells. Int. J. Cancer 131, E21-E32 (2012).
30. Stadler, M. B. et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480, 490-495 (2011).
31. Milde, T. et al. HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment. J. Neurooncol. 110, 335-348 (2012).
32. Richter, J. et al. Recurrentmutation of the ID3 gene in Burkitt lymphomaidentified by integrated genome, exome and transcriptome sequencing. Nature Genet. 44, 1316-1320 (2012).
33. Lister, R. et al.Hotspots ofaberrantepigenomic reprogramming inhumaninduced pluripotent stem cells. Nature 471, 68-73 (2011).
34. Jones, D. T. W. et al. Recurrent somatic alterations ofFGFR1 andNTRK2 in pilocytic astrocytoma. Nature Genet. 45, 927-932 (2013).
35. Hafner, M. et al. Identification of micro RNA sandothersmall regulatory RNAs using cDNA library sequencing. Methods 44, 3-12 (2008).
36. Bunt, J. et al. Joint binding of OTX 2 and MY Cin promotor regions is associated with high gene expression in medulloblastoma. PLoS ONE 6, e26058 (2011).
37. Krueger, F. & Andrews, S. R. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics 27, 1571-1572 (2011).
38. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
39. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21 (2013).
40. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature Biotechnol. 28, 511-515 (2010).
41. Kozomara, A.& Griffiths-Jones, S. miRBase: integrating microRNAannotation and deep-sequencing data. Nucleic Acids Res. 39, D152-D157 (2011).
42. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
43. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
44. R Development Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2010).
45. Burger, L., Gaidatzis, D., Schubeler, D. & Stadler, M. B. Identification of active regulatory regions from DNA methylation data. Nucleic Acids Res. 41, e155 (2013).
46. Jolma, A. et al. DNA-binding specificities of human transcription factors. Cell 152, 327-339 (2013).
47. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
48. Li, H. et al. Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo. Proc. Natl Acad. Sci. USA 105, 9397-9402 (2008).